Side Effects of Different Doses of Ephedrine in Rats with Cerebral Ischemia/Reperfusion Injury

Ling Liu,Liyun Lin,Nong Xiao,Yuxia Chen,Siyuan Chen
DOI: https://doi.org/10.3969/j.issn.1673-5374.2010.24.007
2010-01-01
Neural Regeneration Research
Abstract:Ephedrine has a protective effect against cerebral ischemia, but its side effects limit its clinical application. Results from a previous study showed that 1.5 mg/kg per day ephedrine can promote motion recovery in rats following cerebral ischemia/reperfusion without significant side effects. In the present study, ephedrine at doses of 3.0, 2.5 and 2.0 mg/kg was used to treat rats with cerebral ischemia/reperfusion and the effects of ephedrine on the heart, liver, kidney and cerebrum were observed. Results showed that the blood pressure of rats with cerebral ischemia/reperfusion injury following ephedrine treatment was lower than in rats that recovered naturally from cerebral ischemia/reperfusion, but the pressure decreased with increasing doses of ephedrine. In addition, serum aspartate transaminase, alkaline phosphatase and creatinine concentration in rats with cerebral ischemia/reperfusion injury following ephedrine treatment were greater than in rats that recovered naturally from cerebral ischemia/reperfusion. The concentrations of these enzymes were decreased with increasing doses of ephedrine. Ephedrine-treated rats displayed hyperemia, degeneration and edema in the cerebrum, liver, heart and kidney. Results demonstrated that ephedrine exhibited side effects on the cerebrum, heart, liver and kidney in rats following cerebral ischemia/reperfusion in a dose-dependent manner.
What problem does this paper attempt to address?